The Use of Trastuzumab in Metastatic Breast Cancer

The Impact of Trastuzumab Administration Patterns on the Long-Term Clinical Outcomes of Patients with Non-Metastatic Breast Cancer in a Resource-Limited Setting

Role of Metformin in Combination with Trastuzumab and Neoadjuvant Chemotherapy in Treatment of HER-2 Positive Breast Cancer

Clinical outcome of lapatinib and capecitabine in Her-2 +ve advanced/ metastatic breast cancer patients: A prospective study

Clinico-Pathological Study of Prognostic Factors in HER-2 Positive Patients with Breast Cancer

Cardiotoxic Effect of Adjuvant Subcutaneous versus Intravenous Trastuzumab in HER-2 Positive Breast Cancer

Medical Management of Women with Breast Cancer

Tumor Infiltrating Lymphocytes Predicting Long-Term Outcomes in HER2-Negative Breast Cancer Patients with Visceral Metastases

Prognostic Value of HER2 in Metastatic Colorectal Cancer: A Single Institutional Experience

Survival rate and prognosis of single hormone receptor positive breast cancer.